These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19235343)

  • 1. [Impulse control disorder induced by the use of dopamine agonists].
    Weber WE; Nijssen PC
    Ned Tijdschr Geneeskd; 2009 Jan; 153(3):80-1. PubMed ID: 19235343
    [No Abstract]   [Full Text] [Related]  

  • 2. Sleep attacks in patients receiving dopamine-receptor agonists.
    Plowman BK; Boggie DT; Morreale AP; Schaefer MG; Delattre ML; Chan H
    Am J Health Syst Pharm; 2005 Mar; 62(5):537-40. PubMed ID: 15745920
    [No Abstract]   [Full Text] [Related]  

  • 3. Punding in patients on dopamine agonists for restless leg syndrome.
    Evans AH; Stegeman JR
    Mov Disord; 2009 Jan; 24(1):140-1. PubMed ID: 18855926
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical hazards of the internet: gambling in Parkinson's disease.
    Larner AJ
    Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
    Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
    Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.
    Ahlskog JE
    Physiol Behav; 2011 Jul; 104(1):168-72. PubMed ID: 21557955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.
    Launois C; Leu-Semenescu S; Brion A; Arnulf I
    Sleep Med; 2013 Jul; 14(7):696. PubMed ID: 23714418
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists.
    Tippmann-Peikert M; Park JG; Boeve BF; Shepard JW; Silber MH
    Neurology; 2007 Jan; 68(4):301-3. PubMed ID: 17242339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of juvenile Parkinson disease and the recurrent emergence of pathologic gambling.
    Garcia RF; Ordacgi L; Mendlowicz MV; de Freitas GR; Rosso AL; Nazar BP; Fontenelle LF
    Cogn Behav Neurol; 2007 Mar; 20(1):11-4. PubMed ID: 17356338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.
    Evans AH; Butzkueven H
    Mov Disord; 2007 Mar; 22(4):590-1. PubMed ID: 17230484
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome.
    Dorfman BJ; Nirenberg MJ
    Parkinsonism Relat Disord; 2013 Feb; 19(2):269-70. PubMed ID: 22749683
    [No Abstract]   [Full Text] [Related]  

  • 12. Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample.
    Allen RP; Ondo WG; Ball E; Calloway MO; Manjunath R; Higbie RL; Lee MR; Nisbet PA
    Sleep Med; 2011 May; 12(5):431-9. PubMed ID: 21493132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pramipexole (Mirapex) for restless legs syndrome.
    Med Lett Drugs Ther; 2007 Mar; 49(1257):26-8. PubMed ID: 17375031
    [No Abstract]   [Full Text] [Related]  

  • 14. Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
    Bares M; Rektorová I; Krajcovicová L; Rektor I
    J Neurol; 2008 Oct; 255(10):1596; author reply 1597. PubMed ID: 18758889
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
    Bayard S; Cochen De Cock V; Dauvillers Y
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pramipexole: new indication. Restless legs: still no satisfactory drug treatment.
    Prescrire Int; 2007 Feb; 16(87):12. PubMed ID: 17323517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS.
    Varga LI; Ako-Agugua N; Colasante J; Hertweck L; Houser T; Smith J; Watty AA; Nagar S; Raffa RB
    J Clin Pharm Ther; 2009 Oct; 34(5):493-505. PubMed ID: 19744006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of devastating impulse control disorders during dopamine agonist therapy of the restless legs syndrome.
    Dang D; Cunnington D; Swieca J
    Clin Neuropharmacol; 2011; 34(2):66-70. PubMed ID: 21412200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropinirole in restless leg syndrome.
    Ahmed I
    Mo Med; 2002; 99(9):500-1. PubMed ID: 12462942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide].
    van Laar T; Berendse H; Bloem BR; Boon AJ; van Hilten JJ; Hovestadt A; de Koning-Tijssen MA; Nijssen PC; Weber WE
    Ned Tijdschr Geneeskd; 2009 Jan; 153(3):87-90. PubMed ID: 19235345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.